BridgeBio Pharma annual asset turnover
2019
2020
2021
2022
2023
2024
2025
BridgeBio Pharma Asset Turnover Growth & History (BBIO)
BridgeBio Pharma's asset turnover was 0.54 for fiscal 2025.
View full BridgeBio Pharma company overviewBridgeBio Pharma annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.54 | 0.24 | +78.74% |
| 2024 | 2024-12-31 | 0.30 | 0.29 | +1803.08% |
| 2023 | 2023-12-31 | 0.02 | −0.08 | −83.24% |
| 2022 | 2022-12-31 | 0.09 | 0.01 | +16.86% |
| 2021 | 2021-12-31 | 0.08 | 0.07 | +557.48% |
| 2020 | 2020-12-31 | 0.01 | −0.06 | −83.30% |
| 2019 | 2019-12-31 | 0.07 | — | — |
BridgeBio Pharma quarterly asset turnover
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Asset turnover | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.62 | 0.37 | +146.72% |
| Q1 2026 | 2026-03-31 | 0.51 | 0.37 | +249.77% |
| Q4 2025 | 2025-12-31 | 0.54 | 0.24 | +78.74% |
| Q3 2025 | 2025-09-30 | 0.43 | 0.10 | +28.93% |
| Q2 2025 | 2025-06-30 | 0.25 | −0.09 | −25.48% |
| Q1 2025 | 2025-03-31 | 0.15 | −0.15 | −50.33% |
| Q4 2024 | 2024-12-31 | 0.30 | 0.29 | +1803.08% |
| Q3 2024 | 2024-09-30 | 0.33 | 0.32 | +2321.34% |
| Q2 2024 | 2024-06-30 | 0.34 | 0.33 | +3963.07% |
| Q1 2024 | 2024-03-31 | 0.30 | 0.19 | +174.15% |
| Q4 2023 | 2023-12-31 | 0.02 | −0.08 | −83.24% |
| Q3 2023 | 2023-09-30 | 0.01 | −0.10 | −88.39% |
| Q2 2023 | 2023-06-30 | 0.01 | −0.08 | −91.09% |
| Q1 2023 | 2023-03-31 | 0.11 | 0.03 | +45.26% |
| Q4 2022 | 2022-12-31 | 0.09 | 0.01 | +16.86% |
| Q3 2022 | 2022-09-30 | 0.12 | — | — |
| Q2 2022 | 2022-06-30 | 0.09 | — | — |
| Q1 2022 | 2022-03-31 | 0.07 | — | — |
| Q4 2021 | 2021-12-31 | 0.08 | — | — |
BridgeBio Pharma asset turnover trends
Over the last five fiscal years, BridgeBio Pharma's asset turnover increased from 0.01 to 0.54, a change of 0.53. The latest reported quarter, Q2 2026, shows 0.62.
About the metric
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
Calculation and source
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BridgeBio Pharma source filings ↗Community posts
BridgeBio’s Attruby sales expand as a one-time milestone boosts quarterly revenue
BridgeBio ($BBIO) reported third-quarter 2026 revenue of $353.2 million, compared with $120.7 million a year earlier. US Attruby sales reached $253.2 million, increasing approximately $31 million sequentially and $145 million year over year ...
